ST
Insider
Sharon Townson
Chief Scientific OfficerSharon Townson (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Monte Rosa Therapeutics, Inc. (GLUE). The largest single filing was $130K of GLUE (5,600 sh × $23.25, as filed), executed Jul 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$249K
shares × price, as filed
Last traded
Jul 6
Filed Jul 7
Median ADV $21.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $249K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
GLUERecent filings
GLUESALE
Monte Rosa Therapeutics, Inc.
View filing →
$130K5,600 sh × $23.25
Exec Jul 6
Filed Jul 7 · 4:41 PM ET GLUESALE Monte Rosa Therapeutics, Inc. View filing → $119K
6,000 sh × $19.87
Exec May 29
Filed Jun 1 · 5:30 PM ET